Literature DB >> 27347888

Reproductive Steroid Regulation of Mood and Behavior.

Crystal Edler Schiller1, Sarah L Johnson1, Anna C Abate1, Peter J Schmidt2, David R Rubinow1.   

Abstract

In this article, we examine evidence supporting the role of reproductive steroids in the regulation of mood and behavior in women and the nature of that role. In the first half of the article, we review evidence for the following: (i) the reproductive system is designed to regulate behavior; (ii) from the subcellular to cellular to circuit to behavior, reproductive steroids are powerful neuroregulators; (iii) affective disorders are disorders of behavioral state; and (iv) reproductive steroids affect virtually every system implicated in the pathophysiology of depression. In the second half of the article, we discuss the diagnosis of the three reproductive endocrine-related mood disorders (premenstrual dysphoric disorder, postpartum depression, and perimenopausal depression) and present evidence supporting the relevance of reproductive steroids to these conditions. Existing evidence suggests that changes in reproductive steroid levels during specific reproductive states (i.e., the premenstrual phase of the menstrual cycle, pregnancy, parturition, and the menopause transition) trigger affective dysregulation in susceptible women, thus suggesting the etiopathogenic relevance of these hormonal changes in reproductive mood disorders. Understanding the source of individual susceptibility is critical to both preventing the onset of illness and developing novel, individualized treatments for reproductive-related affective dysregulation. © 2016 American Physiological Society. Compr Physiol 6:1135-1160, 2016e.
Copyright © 2016 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27347888      PMCID: PMC6309888          DOI: 10.1002/cphy.c150014

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  44 in total

1.  Adverse life events, psychiatric history, and biological predictors of postpartum depression in an ethnically diverse sample of postpartum women.

Authors:  J Guintivano; P F Sullivan; A M Stuebe; T Penders; J Thorp; D R Rubinow; S Meltzer-Brody
Journal:  Psychol Med       Date:  2017-09-27       Impact factor: 7.723

2.  Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels.

Authors:  Peter J Schmidt; Pedro E Martinez; Lynnette K Nieman; Deloris E Koziol; Karla D Thompson; Linda Schenkel; Paul G Wakim; David R Rubinow
Journal:  Am J Psychiatry       Date:  2017-04-21       Impact factor: 18.112

3.  Brain-derived neurotrophic factor Val66Met genotype and ovarian steroids interactively modulate working memory-related hippocampal function in women: a multimodal neuroimaging study.

Authors:  S-M Wei; E B Baller; P D Kohn; J S Kippenhan; B Kolachana; S J Soldin; D R Rubinow; P J Schmidt; K F Berman
Journal:  Mol Psychiatry       Date:  2017-04-18       Impact factor: 15.992

Review 4.  The Dynamics of Neurosteroids and Sex-Related Hormones in the Pathogenesis of Alzheimer's Disease.

Authors:  Milad Hasanpour; Alireza Nourazarian; Mohammad Hossein Geranmayeh; Masoud Nikanfar; Fatemeh Khaki-Khatibi; Reza Rahbarghazi
Journal:  Neuromolecular Med       Date:  2018-05-04       Impact factor: 3.843

5.  Do dehydroepiandrosterone, progesterone, and testosterone influence women's depression and anxiety levels? Evidence from hair-based hormonal measures of 2105 rural Indian women.

Authors:  A Walther; C Tsao; R Pande; C Kirschbaum; E Field; L Berkman
Journal:  Psychoneuroendocrinology       Date:  2019-07-19       Impact factor: 4.905

6.  Sex-specific disease-associated modules for depression.

Authors:  Ronald S Duman
Journal:  Nat Med       Date:  2017-09-08       Impact factor: 53.440

Review 7.  Suicide Risk and the Menstrual Cycle: a Review of Candidate RDoC Mechanisms.

Authors:  Sarah A Owens; Tory Eisenlohr-Moul
Journal:  Curr Psychiatry Rep       Date:  2018-10-06       Impact factor: 5.285

8.  Differential effects of the menstrual cycle on reactive and proactive aggression in borderline personality disorder.

Authors:  Jessica R Peters; Sarah A Owens; Katja M Schmalenberger; Tory A Eisenlohr-Moul
Journal:  Aggress Behav       Date:  2020-01-20       Impact factor: 2.917

Review 9.  Ovarian Hormones as a Source of Fluctuating Biological Vulnerability in Borderline Personality Disorder.

Authors:  Jessica R Peters; Tory A Eisenlohr-Moul
Journal:  Curr Psychiatry Rep       Date:  2019-10-17       Impact factor: 5.285

10.  THE NEUROENDOCRINOLOGICAL ASPECTS OF PREGNANCY AND POSTPARTUM DEPRESSION.

Authors:  S Trifu; A Vladuti; A Popescu
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Jul-Sep       Impact factor: 0.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.